Melatonin protects against MPTP/MPP+-induced mitochondrial DNA oxidative damage in vivo and in vitro

Journal of Pineal Research

Volumn 39, Issue 1, 2005, Pages 34-42

  Chen, Liu Ji ^a   Gao, Yan Qin ^a   Li, Xue Jun ^a   Shen, Di Han ^a   Sun, Feng Yan ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

1 methyl 4 phenyl 1, 2, 3, 6 tetrahydropyridine; Melatonin; Mitochondria DNA oxidative damage; Mitochondrial membrane potential; Mitochondrial oxygen free radicals

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 8 HYDROXYGUANINE; BIOLOGICAL MARKER; MELATONIN; MITOCHONDRIAL DNA; OXYGEN RADICAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL NUCLEUS; CELL PROTECTION; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 1-METHYL-4-PHENYLPYRIDINIUM; ADJUVANTS, IMMUNOLOGIC; ANIMALS; BRAIN; BRAIN CHEMISTRY; CELL DEATH; DNA DAMAGE; DNA, MITOCHONDRIAL; DOPAMINE AGENTS; HERBICIDES; MALE; MELATONIN; MICE; MPTP POISONING;

EID: 22044448363     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2005.00209.x     Document Type: Article

References (48)

1. UHL GR, JAVITCH JA, SNYDER SH. Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brain. Lancet 1985; 1:956-957.
2. PRZEDBORSKI S, JACKSON-LEWIS V. Mechanisms of MPTP toxicity. Mov Disord 1998; 13(Suppl. 1):35-38.
3. ADAMS JD Jr, KLAIDMAN LK, LEUNG AC. MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes. Free Radic Biol Med 1993; 15:181-186.
4. PRZEDBORSKI S, JACKSON-LEWIS V, YOKOYAMA R et al. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 1996; 93:4565-4571.
5. DENNIS J, BENNETT JP Jr. Interactions among nitric oxide and Bcl-family proteins after MPP+ exposure of SH-SY5Y neural cells I: MPP+ increases mitochondrial NO and Bax protein. J Neurosci Res 2003; 72:76-88.
6. GAO HM, HONG JS, ZHANG W et al. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J Neurosci 2003; 23:1228-1236.
7. MANDAVILLI BS, ALI SF, VAN HOUTEN B. DNA damage in brain mitochondria caused by aging and MPTP treatment. Brain Res 2000; 885:45-52.
8. DUNNETT SB, BJORKLUND A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 1999; 399:A32-A39.
9. TEIXEIRA A, MORFIM MP, DE CORDOVA CA et al. Melatonin protects against pro-oxidant enzymes and reduces lipid peroxidation in distinct membranes induced by the hydroxyl and ascorbyl radicals and by peroxynitrite. J Pineal Res 2003; 35:262-268.
10. ACUNA-CASTROVIEJO D, MARTIN M, MACIAS M et al. Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 2001; 30:65-74.
11. ACUNA-CASTROVIEJO D, ESCAMES G, MACIAS M et al. Cell protective role of melatonin in the brain. J Pineal Res 1995; 19:57-63.
12. CRESPO E, MACIAS M, POZO D et al. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999; 13:1537-1546.
13. DABBENI-SALA F, DI SANTO S, FRANCESCHINI D et al. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J 2001; 15:164-170.
14. LI XJ, ZHANG LM, GU J et al. Melatonin decreases production of hydroxyl radical during cerebral ischemia-reperfusion. Zhongguo Yao Li Xue Bao 1997; 18:394-396.
15. LI XJ, GU J, PAN BS et al. Effect of melatonin on production of hydroxyl radical and lactate dehydrogenase during hypoxia in rat cortical slices. Zhongguo Yao Li Xue Bao 1999; 20:201-205.
16. SUN FY, LIN X, MAO LZ et al. Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J Pineal Res 2002; 33:48-56.
17. ACUNA-CASTROVIEJO D, COTO-MONTES A, GAIA MONTI M et al. Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci 1997; 60:PL23-PL29.
18. LI XJ, GU J, LU SD et al. Melatonin attenuates MPTP-induced dopaminergic neuronal injury associated with scavenging hydroxyl radical. J Pineal Res 2002; 32:47-52.
19. ORTIZ GG, CRESPO-LOPEZ ME, MORAN-MOGUEL C et al. Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo. Neuro Endocrinol Lett 2001; 22:101-108.
20. KHALDY H, ESCAMES G, LEON J et al. Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion. Neurobiol Aging 2003; 24:491-500.
21. IACOVITTI L, STULL ND, JOHNSTON K. Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress. Brain Res 1997; 768:317-326.
22. ABSI E, AYALA A, MACHADO A et al. Protective effect of melatonin against the 1-methyl-4-phenylpyridinium-induced inhibition of complex I of the mitochondrial respiratory chain. J Pineal Res 2000; 29:40-47.
23. OZAWA T, TANAKA M, INO H et al. Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem Biophys Res Commun 1991; 176:938-946.
24. BROWN MD, SHOFFNER JM, KIM YL et al. Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. Am J Med Genet 1996; 61:283-289.
25. ZHANG J, PERRY G, SMITH MA et al. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol 1999; 154:1423-1429.
26. QIU MH, ZHANG R, SUN FY. Enhancement of ischemia-induced tyrosine phosphorylation of Kv1.2 by vascular endothelial growth factor via activation of phosphatidylinositol 3-kinase. J Neurochem 2003; 87:1509-1517.
27. ROSEBOOM PH, NAMBOODIRI MA, ZIMONJIC DB et al. Natural melatonin 'knockdown' in C57BL/6J mice: rare mechanism truncates serotonin N-acetyltransferase. Brain Res Mol Brain Res 1998; 63:189-197.
28. EBIHARA S, MARKS T, HUDSON DJ et al. Genetic control of melatonin synthesis in the pineal gland of the mouse. Science 1986; 231:491-493.
29. LING X, ZHANG LM, LU SD et al. Protective effect of melatonin on injured cerebral neurons is associated with bcl-2 protein over-expression. Zhongguo Yao Li Xue Bao 1999; 20:409-414.
30. NANGAKU M, SATO-YOSHITAKE R, OKADA Y et al. KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 1994; 79:1209-1220.
31. KIM DY, WON SJ, GWAG BJ. Analysis of mitochondrial free radical generation in animal models of neuronal disease. Free Radic Biol Med 2002; 33:715-723.
32. WHITE RJ, REYNOLDS IJ. Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure. J Neurosci 1996; 16:5688-5697.
33. MOSMANN T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
34. OLANOW CW. Oxidation reactions in Parkinson's disease. Neurology 1990; 40(Suppl.):32-37; discussion 37-39.
35. GOTZ ME, FREYBERGER A, RIEDERER P. Oxidative stress: a role in the pathogenesis of Parkinson's disease. J Neural Transm Suppl 1990; 29:241-249.
36. GILGUN-SHERKI Y, ROSENBAUM Z, MELAMED E et al. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 2002; 54:271-284.
37. OZAWA T, TANAKA M, IKEBE S et al. Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. Biochem Biophys Res Commun 1990; 172:483-489.
38. ZAMZAMI N, MARCHETTI P, CASTEDO M et al. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 1996; 384:53-57.
39. REGO AC, OLIVEIRA CR. Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem Res 2003; 28:1563-1574.
40. OKATANI Y, WAKATSUKI A, KANEDA C. Melatonin increases activities of glutathione peroxidase and Superoxide dismutase in fetal rat brain. J Pineal Res 2000; 28:89-96.
41. OTHMAN AI, EL-MISSIRY MA, AMER MA. The protective action of melatonin on indomethacin-induced gastric and testicular oxidative stress in rats. Redox Rep 2001; 6:173-177.
42. JOU MJ, PENG TI, REITER RJ et al. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res 2004; 37:55-70.
43. LEON J, ACUNA-CASTROVIEJO D, SAINZ RM et al. Melatonin and mitochondrial function. Life Sci 2004; 75:765-790.
44. XU M, ASHRAF M. Melatonin protection against lethal myocyte injury induced by doxorubicin as reflected by effects on mitochondrial membrane potential. J Mol Cell Cardiol 2002; 34:75-79.
45. YAMAMOTO HA, MOHANAN PV. In vivo and in vitro effects of melatonin or ganglioside GTlB on L-cysteine-induced brain mitochondrial DNA damage in mice. Toxicol Sci 2003; 73:416-422.
46. PAPPOLLA MA, CHYAN YJ, POEGGELER B et al. Alzheimer beta protein mediated oxidative damage of mitochondrial DNA: prevention by melatonin. J Pineal Res 1999; 27:226-229.
47. YAMAMOTO HA, MOHANAN PV. Ganglioside GT1B and melatonin inhibit brain mitochondrial DNA damage and seizures induced by kainic acid in mice. Brain Res 2003; 964:100-106.
48. ANDRABI SA, SAYEED I, SIEMEN D et al. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 2004; 18:869-871.